EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Novel immune checkpoint targets: A promising therapy for cancer treatments

Mohsina Patwekar, Nouroz Sehar, Faheem Patwekar, Anuradha Medikeri, Shafat Ali, Rana M Aldossri, Muneeb U Rehman

International Immunopharmacology · 2024

DOI: 10.1016/j.intimp.2023.111186 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Mohsina Patwekar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Luqman College of Pharmacy, Gulbarga, 585102, Karnataka, India. Electronic address: mohsina.patwekar@gmail.com. Hauptthemen laut MEDLINE: Immune Checkpoint Proteins, Neoplasms. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 149 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immune Checkpoint ProteinsNeoplasmsHumansAntibodies, MonoclonalImmunotherapyCTLA-4 AntigenT-LymphocytesB7-H1 Antigen

Stichwörter der Autor:innen

B7-H6 ligandGalectin 3HHLA2 proteinNKG2A ligandsTIGITTIM3

Substanzen

Immune Checkpoint ProteinsAntibodies, MonoclonalCTLA-4 AntigenB7-H1 Antigen

Autor:innen und Institutionen

  • Luqman College of Pharmacy, Gulbarga, 585102, Karnataka, India. Electronic address: mohsina.patwekar@gmail.com.
  • Centre for Translational and Clinical Research, School of Chemical and Life Sciences, Jamia Hamdard University, New Delhi, 110062, India.
  • Luqman College of Pharmacy, Gulbarga, 585102, Karnataka, India.
  • Cytogenetics and Molecular Biology Laboratory, Centre of Research for Development, University of Kashmir, Srinagar, 190006, Jammu and Kashmir, India. Electronic address: rahilshafat986@gmail.com.
  • Department of Pharmacology and Toxicology, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj, 11942, Saudi Arabia.
  • Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, 11451, Saudi Arabia.

Zitieren

APA

Patwekar, M., Sehar, N., Patwekar, F., Medikeri, A., Ali, S., Aldossri, R. M., & Rehman, M. U. (2024). Novel immune checkpoint targets: A promising therapy for cancer treatments. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.111186

Vancouver

Patwekar M, Sehar N, Patwekar F, Medikeri A, Ali S, Aldossri RM, et al. Novel immune checkpoint targets: A promising therapy for cancer treatments. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2023.111186

BibTeX
@article{Patwekar2024,
  author = {Patwekar, Mohsina and Sehar, Nouroz and Patwekar, Faheem and Medikeri, Anuradha and Ali, Shafat and Aldossri, Rana M and Rehman, Muneeb U},
  title = {Novel immune checkpoint targets: A promising therapy for cancer treatments},
  journal = {International Immunopharmacology},
  year = {2024},
  doi = {10.1016/j.intimp.2023.111186}
}
Kostenlos starten →